8212199

pubmed:Citation

4

Glycine has been shown to protect renal tubule cells and hepatocytes from ischemia, ATP depletion, and cold storage injury. Glycine may be a useful additive to organ preservation solutions or suppress reperfusion injury by infusion into recipients of liver transplantation. In this study, the effects of glycine on survival and postoperative liver injury were studied in the rat and dog orthotopic transplant model. Rat livers preserved for 30 hr in the University of Wisconsin (UW) solution were 50% viable (3 of 6 survivors for 7 days). When glutathione was replaced by 10 mM glycine, survival increased to 100% (6 of 6). There was a significant reduction in hepatocellular injury at the end of preservation (lactate dehydrogenase [LDH] in the pretransplant flush-out of the liver was lower in the glycine group) and after transplantation (serum LDH concentration 6 hr after transplant was lower in the glycine group). In the dog, omission of glutathione from the UW solution resulted in 33% survival (48-hr preservation model) versus 100% survival with glutathione. Replacing glutathione in the UW solution by glycine did not improve survival (33% after 48 hr of preservation). However, when glycine was given to recipients of livers preserved in the UW solution for 24 or 48 hr, there was a decrease in the degree of hepatocellular injury. After 48 hr of preservation, peak aspartate aminotransferase, alanine aminotransferase, and LDH were reduced by about 45-55% when glycine was given to the recipient. Although the differences, with and without glycine treatment of the recipients, did not reach statistical significance, there was a noticeable reduction in hepatocellular injury with glycine. There was 100% survival of dogs in the groups that received livers preserved with the UW solution plus or minus glycine infusion. Hepatamine, a parenteral nutrition solution containing glycine and other amino acids increased hepatocellular injury (higher concentrations of aspartate aminotransferase, alanine transferase, and LDH versus control 48-hr preserved livers), although all dogs survived. This study shows that glycine is cytoprotective when administered to recipients of livers preserved for 24 or 48 hr and suppresses hepatocellular injury, as reflected in a reduction in the concentration of serum enzymes. However, the differences, with and without glycine, were, at best, marginal and further studies are needed to determine whether glycine would make a significant improvement in liver preservation and prevent primary nonfunction.

eng

IM

MEDLINE

0041-1337

Print

NLM

817-22

pubmed-meshheading:8212199-Adenosine, pubmed-meshheading:8212199-Alanine Transaminase, pubmed-meshheading:8212199-Allopurinol, pubmed-meshheading:8212199-Animals, pubmed-meshheading:8212199-Aspartate Aminotransferases, pubmed-meshheading:8212199-Dogs, pubmed-meshheading:8212199-Female, pubmed-meshheading:8212199-Glutathione, pubmed-meshheading:8212199-Glycine, pubmed-meshheading:8212199-Graft Rejection, pubmed-meshheading:8212199-Graft Survival, pubmed-meshheading:8212199-Insulin, pubmed-meshheading:8212199-L-Lactate Dehydrogenase, pubmed-meshheading:8212199-Liver, pubmed-meshheading:8212199-Liver Transplantation, pubmed-meshheading:8212199-Male, pubmed-meshheading:8212199-Organ Preservation, pubmed-meshheading:8212199-Organ Preservation Solutions, pubmed-meshheading:8212199-Raffinose, pubmed-meshheading:8212199-Rats, pubmed-meshheading:8212199-Rats, Inbred BN, pubmed-meshheading:8212199-Time Factors

Effect of glycine in dog and rat liver transplantation.

Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't